Professor of Neurology, Neurosurgery and Medicine (Medical Oncology) University of Pittsburgh School of Medicine
Neurology
Dr. Frank S. Lieberman, MD
|
|
Give Review
Frank S. Lieberman practices Neurology. He went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. Frank Lieberman is a published doctor. He has 64 publications published. The most current publication "Bilateral optic neuropathy with IgGkappa multiple myeloma improved after myeloablative chemotherapy." Frank S. Lieberman, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central Nervous system tumors.
- A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.
- Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.
- First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy.
- Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
- Molecular and metabolic pattern classification for detection of Brain glioma progression.
- The accuracy of predicting survival in individual patients with Cancer.
- Long-Term Health Experience of Jet Engine Manufacturing Workers: Results From a 12-Year Exploratory Investigation.
- Distinguishing Pseudoprogression From Progression in High-Grade Gliomas: A Brief Review of Current Clinical Practice and Demonstration of the Potential Value of 18F-FD...
- Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis.
- Primary central nervous system post-transplant lymphoproliferative Disorders following allogeneic hematopoietic stem cell transplantation.
- Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study.
- A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.
- Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells...
- Posterior reversible encephalopathy syndrome (PRES) with immune System activation, VEGF up-regulation, and cerebral amyloid angiopathy.
- Comparison of Proton Magnetic Resonance Spectroscopy with Fluorine-18 2-Fluoro-Deoxyglucose Positron Emission Tomography for Assessment of Brain Tumor Progression.
- Long-term health experience of jet engine manufacturing workers: IV. A comparison of central Nervous system cancer ascertainment using mortality and incidence data.
- ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of Gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the b...
- Methodological issues in a retrospective Cancer incidence study.
- Long-term health experience of jet engine manufacturing workers: II. Total and cause-specific mortality excluding central Nervous system neoplasms.
- Long-term health experience of jet engine manufacturing workers: I. Mortality from central Nervous system neoplasms.
- Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 ...
- Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
- Microdissection-based genotyping assists Discrimination of reactive gliosis from glioma.
- Distant effects of cancer on the Nervous system.
- Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
- Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patien...
- Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.
- Malignant Gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods.
- Bilateral optic Neuropathy with IgGkappa multiple myeloma improved after myeloablative chemotherapy.
- Anti-histone antibodies in subacute sensory Neuropathy.
- Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
- Inhibition of proliferation and induction of differentiation in medulloblastoma- and Astrocytoma-derived cell lines with phenylacetate.
- Identifying Muir-Torre Syndrome in a patient with glioblastoma multiforme.
- Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study.
- A North American Brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.
- Molecular abnormalities and correlations with tumor response and outcome in glioma patients.
- Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study.
- Microdissection genotyping of Gliomas: therapeutic and prognostic considerations.
- Does radiosurgery have a role in the management of oligodendroGliomas?
- Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
- Gene therapy of malignant Gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elici...
- A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant Gliomas and meningiomas.
- Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain ...
- Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
- Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
- Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american Brain tumor co...
- Internalization of anti-Hu IgG is not Fc gamma receptor mediated.
- A phase II trial of erlotinib in patients with recurrent malignant Gliomas and nonprogressive glioblastoma multiforme postradiation therapy.
- Gene therapy of malignant Gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.
- Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
- Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
- Nuclear localization of anti-Hu antibody is not associated with in vitro cytoToxicity.
- Headaches after inadvertent lumbar puncture during bone marrow harvest.
- Advances in neurofibromatosis 2 (NF2): a workshop report.
- Diagnosis, management, and evaluation of chemotherapy-induced peripheral Neuropathy.
- Non-invasive assessment of tumor proliferation using triple quantum filtered 23/Na MRI: technical challenges and solutions.
- Pattern of reactivity of IgM from the sera of eight patients with IgM monoclonal gammopathy and Neuropathy with components of neural tissues: evidence for interaction ...
- A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.
- Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
- Long-term health experience of jet engine manufacturing workers: III. Incidence of malignant central Nervous system neoplasms.
- Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant Gliomas.
- Progression-free survival: an important end point in evaluating therapy for recurrent high-grade Gliomas.
Schools
University Of ChicagoThe Pritzker School Of Medicine
University Of Chicago Hosps
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Ataxia
- Autonomic Disorders
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- View All
Doctors Specialties
- Neurology
Accepted Insurances
- Aetna HMO
- Blue Card PPO
- Great West Healthcare-Cigna PPO
- Highmark Blue Cross Blue Shield
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- UPMC PPO
Education
-
University of Chicago -
University of Chicago Pritzker School of Medicine
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1073587218 | |
| NPPES Provider LastName | LIEBERMAN | |
| NPPES Provider FirstName | FRANK | |
| NPPES Provider ZIPCode | 152321309 | |
| NPPES Provider State | PA | |
| Specialty Description | Neurology | |
| Total Claim Count | 563.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073587218 |
| Last Name Of The Provider | LIEBERMAN |
| First Name Of The Provider | FRANK |
| View All |
Similar Doctors
|
|
Dr. Daniel Varon, MD |
|
|
Dr. Robert Y. Moore, MD |
|
|
Dr. Amar B. Bhatt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. Doyle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael E. Reznik, MD |
|
|
Dr. Deeksha Agrawal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramnath S. Ramanathan, MD |
|
|
Dr. Victoria Titoff, DO |